SCHEMBL30582547

SCHEMBL30582547

Cn1c(C2=CCC3(CCNCC3)CC2)c(-c2ncc(C#N)cn2)c2c(N)ncnc21

nearest known ligand 0.39

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ LRRK2 Q5S007 10/20 0.39
▸ DYRK1A Q13627 1/20 0.37
▸ RET P07949 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26108241 1.00 LRRK2 (0.39) LRRK2DYRK1ARET
SCHEMBL31219432 0.89 RET (0.33) LRRK2RET
SCHEMBL26107963 0.88 LRRK2 (0.34) LRRK2DYRK1ARET
SCHEMBL26106829 0.87 SOS1 (0.31) —
SCHEMBL26106237 0.85 DYRK1A (0.33) DYRK1A
SCHEMBL30582602 0.85 DYRK1A (0.33) DYRK1A
SCHEMBL30582497 0.84 NUDT14 (0.37) —
SCHEMBL26107309 0.84 NUDT14 (0.37) —
SCHEMBL26110628 0.83 RET (0.30) RET
SCHEMBL30582563 0.83 SRC (0.36) LRRK2RET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4499616-A1 SPIROBICYCLIC COMPOUNDS Acerand Therapeutics (Hong Kong) Limited (HK) 2025-02-05 — — EP disclosed
CN-119013260-A Spirobicyclic compounds 优领医药科技(香港)有限公司 2024-11-22 — — CN disclosed
WO-2023192502-A1 SPIROBICYCLIC COMPOUNDS ACERAND THERAPEUTICS (USA) LIMITED (US) 2023-10-05 — — WO disclosed
Send feedback